Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.47 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.45 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.45 |
| ▸ | RELA | Q04206 | 1/20 | 0.45 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.45 |
| ▸ | SSTR4 | P31391 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.42 |
| ▸ | OPRK1 | P41145 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.40 |
| ▸ | ATM | Q13315 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5848088 | 1.00 | CYP4F2 (0.47) | CYP4F2CYP4A11HDAC3HDAC1HDAC2 | |
| SCHEMBL4926783 | 1.00 | CYP4F2 (0.47) | CYP4F2CYP4A11HDAC3HDAC1HDAC2 | |
| SCHEMBL29588217 | 1.00 | CYP4F2 (0.47) | CYP4F2CYP4A11HDAC3HDAC1HDAC2 | |
| SCHEMBL5846876 | 0.84 | HPGD (0.54) | HDAC3HDAC1HDAC2NFKB1NFKB2 | |
| SCHEMBL5846867 | 0.84 | HPGD (0.54) | HDAC3HDAC1HDAC2NFKB1NFKB2 | |
| SCHEMBL3519014 | 0.84 | HPGD (0.54) | HDAC3HDAC1HDAC2NFKB1NFKB2 | |
| SCHEMBL7636320 | 0.84 | CYP4F2 (0.67) | CYP4F2CYP4A11HSD11B1CA2KMT2A | |
| SCHEMBL30783522 | 0.84 | HSD11B1 (0.45) | CYP4F2CYP4A11HDAC3HDAC1HDAC2 | |
| SCHEMBL9739640 | 0.84 | CYP4F2 (0.67) | CYP4F2CYP4A11HSD11B1CA2KMT2A | |
| Fluoride SCHEMBL30783511 | 0.82 | HSD11B1 (0.44) | CYP4F2CYP4A11HDAC3HDAC1HDAC2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240051931-A1 | HDAC INHIBITORS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2024-02-15 | — | — | US | disclosed |
| WO-2022120048-A1 | HDAC INHIBITORS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2022-06-09 | — | — | WO | disclosed |
| WO-2022120048-A1 | HDAC INHIBITORS | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2022-06-09 | — | — | WO | disclosed |
| EP-2817299-B1 | SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS | LUPIN LTD (IN) | 2019-06-12 | — | — | EP | disclosed |
| US-9987249-B2 | Substituted chroman compounds as calcium sensing receptor modulators | LUPIN LIMITED (IN) | 2018-06-05 | — | — | US | disclosed |
| US-9987249-B2 | Substituted chroman compounds as calcium sensing receptor modulators | LUPIN LIMITED (IN) | 2018-06-05 | — | — | US | disclosed |
| US-20170209410-A1 | SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS | LUPIN LIMITED (IN) | 2017-07-27 | — | — | US | disclosed |
| US-20170209410-A1 | SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS | LUPIN LIMITED (IN) | 2017-07-27 | — | — | US | disclosed |
| US-9598391-B2 | Substituted chroman compounds as calcium sensing receptor modulators | LUPIN ATLANTIS HOLDINGS SA (CH) | 2017-03-21 | — | — | US | disclosed |
| US-9598391-B2 | Substituted chroman compounds as calcium sensing receptor modulators | LUPIN ATLANTIS HOLDINGS SA (CH) | 2017-03-21 | — | — | US | disclosed |
| US-20150368222-A1 | SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS | LUPIN LIMITED (IN) | 2015-12-24 | — | — | US | disclosed |
| US-20150368222-A1 | SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS | LUPIN LIMITED (IN) | 2015-12-24 | — | — | US | disclosed |
| US-9163001-B2 | Substituted chroman compounds as calcium sensing receptor modulators | LUPIN LIMITED (IN) | 2015-10-20 | — | — | US | disclosed |
| US-9163001-B2 | Substituted chroman compounds as calcium sensing receptor modulators | LUPIN LIMITED (IN) | 2015-10-20 | — | — | US | disclosed |
| US-20150038546-A1 | SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS | LUPIN LIMITED (IN) | 2015-02-05 | — | — | US | disclosed |
| US-20150038546-A1 | SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS | LUPIN LIMITED (IN) | 2015-02-05 | — | — | US | disclosed |
| WO-2013124828-A1 | SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS | LUPIN LIMITED (IN) | 2013-08-29 | — | — | WO | disclosed |
| US-7034051-B2 | Fused bicyclic carboxamide derivatives and methods of their use | ADOLOR CORPORATION (US) | 2006-04-25 | — | — | US | disclosed |
| WO-2005023799-A1 | FUSED BICYCLIC CARBOXAMIDE DERIVATIVES AND METHODS OF THEIR USE | ADOLOR CORPORATION (US) | 2005-03-17 | — | — | WO | disclosed |
| US-20050054630-A1 | Fused bicyclic carboxamide derivatives and methods of their use | CUBIST PHARMACEUTICALS, INC. | 2005-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368222-A1 | SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS | CASR, RYR2, CALCR | CYP4F2 3208/4885CYP4A11 902/4885HDAC3 1716/4885 |
| US-20240051931-A1 | HDAC INHIBITORS | HDAC8, HDAC1, HDAC2 | CYP4F2 4724/4885CYP4A11 3805/4885HDAC3 4/4885 |
| US-20170209410-A1 | SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS | CASR, RYR2, CALCR | CYP4F2 3208/4885CYP4A11 902/4885HDAC3 1716/4885 |
| US-20150038546-A1 | SUBSTITUTED CHROMAN COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS | CASR, RYR2, CALCR | CYP4F2 3208/4885CYP4A11 902/4885HDAC3 1716/4885 |
| US-20050054630-A1 | Fused bicyclic carboxamide derivatives and methods of their use | PAICS, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, CPS1 | CYP4F2 367/4885CYP4A11 742/4885HDAC3 19/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.